LIVE
Login☆ WatchlistAPI Docs
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommodities
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth
Language
Englishहिन्दीગુજરાતીमराठी

SUPRIYA

NSEBSE
Supriya Lifescience Limited
Healthcare· Pharmaceuticals & Biotechnology· INE07RO01027· Scrip: 543434
ENहिन्दीગુજરાતીमराठी
૬૯૭.૦૦
1.25 (-0.18%)
1/5/2026, 3:28:57 pm
NSE
૬૯૭.૦૦
૧.૨૫
-૦.૧૮%
BSE
૬૯૪.૫૦
૫.૦૫
+૦.૦૦%
56262368474580705-0206-2708-2510-2312-1902-1804-2704-30
૨૪૪ ટ્રેડિંગ દિવસ · 1Y સમયગાળો
આજ
ખૂલ્લ૭૦૩.૦૦
ઊંચ૭૦૩.૩૦
નીચ૬૮૩.૫૫
અગાઉ બંધ૬૯૮.૨૫
વૉલ્યુમ૧.૦૮L
મૂલ્ય₹૭.૫Cr
L: 683.55H: 703.30
52 સપ્તાહ
નીચ૫૪૫.૫૦
ઊંચ૮૩૨.૪૦
૫૩% 52 સપ્તાહ રેન્જમાં
માહિતી
અંકિત મૂલ્ય₹૨
સૂચિબદ્ધ2021-12-28
ISININE07RO01027
SeriesA
BSE સ્ક્રિપ543434

મુખ્ય સૂચકો

1D
-0.18%
1W
+5.11%
1M
+23.50%
3M
-3.70%
6M
-5.63%
મૂલ્યાંકન
P/E (TTM)૩૨.૧૮
P/E (Qtr Ann.)૨૯.૯૪
P/Sales૭.૩૩
વૃદ્ધિ (ત્રિ.)
આવક+11.77%
PAT+1.37%
EPS+1.93%
નફાકારકતા
TTM EBITDA M.૩૮.૨%
TTM આવક
₹671 Cr
TTM EBITDA
₹256 Cr
TTM PAT
₹175 Cr
TTM EPS
₹૨૧.૬૬

ત્રિમાસિક નાણાકીય

આવક
EBITDA
PAT
EPS
0 Cr46 Cr93 Cr139 Cr186 Cr23-0323-0623-0923-1224-0324-0624-0924-124.83.53.03.74.65.55.75.8
ત્રિમાસઆવકExpensesEBITDAPBTPATEPS
2024-12-31186 Cr125 Cr68 Cr63 Cr47 Cr5.82
2024-09-30166 Cr107 Cr67 Cr62 Cr46 Cr5.71
2024-06-30161 Cr103 Cr64 Cr60 Cr45 Cr5.54
2024-03-31158 Cr107 Cr57 Cr53 Cr37 Cr4.59
2023-12-31140 Cr103 Cr44 Cr40 Cr30 Cr3.70
2023-09-30140 Cr113 Cr34 Cr30 Cr24 Cr2.97
2023-06-30132 Cr92 Cr47 Cr43 Cr29 Cr3.54
2023-03-31142 Cr91 Cr56 Cr53 Cr38 Cr4.75

શેરહોલ્ડિંગ પેટર્ન

વર્તમાન2026-03-31
68.3%પ્રમોટર
પ્રમોટર68.3%
FII5.2%
DII5.7%
સાર્વજનિક31.7%
પ્રમોટર હોલ્ડિંગ ટ્રેન્ડ
68.3%24-0668.3%24-0968.3%24-1268.3%25-0368.3%25-0968.3%25-1268.3%26-03

કોર્પોરેટ ક્રિયાઓ

એક્સ-તારીખપ્રકારહેતુ
2025-09-04DividendDividend - Re 1 Per Share
2024-09-20DividendAnnual General Meeting/Dividend - Rs 0.80 Per Share
2023-09-15DividendAnnual General Meeting/Dividend - Re 0.60 Per Share
2022-09-01DividendAnnual General Meeting/Dividend - Re 0.60 Per Share

કમાણી ટ્રાન્સક્રિપ્ટ

Supriya Lifescience Limited has informed the Exchange about Link of Recording of the Earnings Call f...
13 Nov 2025NSE1K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Investor Presentation
12 Nov 2025NSE29K chars
Read →
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201...
9 Nov 2025NSE2K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Investor Presentation
13 Aug 2025NSE28K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Investor Presentation
27 May 2025NSE26K chars
Read →
Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, the details of the Analyst/Investor Meetin...
17 Mar 2025NSE3K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Investor Presentation
24 Jan 2025NSE28K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Investor Presentation
7 Nov 2023NSE29K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Investor Presentation
3 Aug 2023NSE25K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Investor Presentation
27 May 2023NSE29K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Investor Presentation
14 Feb 2023NSE27K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Transcript of Analysts/Institutional Inv...
17 Nov 2022NSE40K chars
Read →
In accordance with Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure ...
11 Nov 2022NSE2K chars
Read →
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,...
11 Nov 2022NSE30K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Schedule of Analysts/Institutional Inves...
3 Nov 2022NSE2K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Schedule of Analysts/Institutional Inves...
30 Aug 2022NSE2K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Schedule of Analysts/Institutional Inves...
25 Aug 2022NSE2K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Schedule of Analysts/Institutional Inves...
24 Aug 2022NSE2K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Transcript of Analysts/Institutional Inv...
23 Aug 2022NSE56K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Recording of Analysts/Institutional Inve...
16 Aug 2022NSE2K chars
Read →

ભાવ ઇતિહાસ

તારીખખૂલ્લઊંચનીચબંધવૉલ્યુમ
2026-04-30૭૦૩.૦૦૭૦૩.૩૦૬૮૩.૫૫૬૯૪.૯૦૧.૦૮L
2026-04-29૭૦૪.૭૦૭૦૭.૮૦૬૯૫.૦૦૬૯૮.૨૫૧.૨૨L
2026-04-28૭૦૯.૦૦૭૧૭.૪૫૭૦૦.૦૦૭૦૪.૭૦૨.૧૫L
2026-04-27૬૬૦.૦૦૭૧૦.૦૦૬૫૫.૦૦૭૦૪.૪૫૧૦.૫૭L
2026-04-24૬૬૩.૫૦૬૬૮.૯૦૬૩૨.૦૫૬૪૨.૮૫૫.૭૮L
2026-04-23૬૫૭.૦૦૬૬૯.૦૦૬૫૦.૧૦૬૬૩.૧૦૧.૬૬L
2026-04-22૬૨૧.૭૫૬૬૦.૦૦૬૨૦.૦૦૬૫૬.૦૦૪.૦૪L
2026-04-21૬૨૪.૭૫૬૨૯.૯૦૬૧૮.૦૦૬૨૦.૭૫૮૫,૨૦૭
2026-04-20૬૪૭.૦૦૬૫૧.૦૦૬૧૫.૧૦૬૧૯.૮૦૨.૨૫L
2026-04-17૬૩૫.૦૦૬૬૫.૬૦૬૧૯.૩૫૬૩૮.૫૦૨.૦૦L
2026-04-16૬૩૮.૪૫૬૪૪.૯૦૬૨૫.૩૫૬૨૮.૩૦૯૦,૯૪૭
2026-04-15૬૪૬.૦૦૬૫૩.૨૦૬૩૧.૩૦૬૩૫.૩૫૧.૧૧L
2026-04-13૬૧૭.૦૦૬૪૨.૪૦૬૧૭.૦૦૬૩૭.૫૫૮૪,૮૦૦
2026-04-10૬૩૪.૯૫૬૪૫.૦૦૬૩૧.૬૫૬૩૮.૭૫૫૭,૨૪૩
2026-04-09૬૨૮.૦૦૬૪૦.૧૫૬૨૪.૬૫૬૨૮.૫૫૭૧,૪૬૭
2026-04-08૬૪૨.૨૫૬૪૨.૨૫૬૨૧.૯૦૬૩૬.૯૫૧.૦૧L
2026-04-07૬૧૮.૯૦૬૧૮.૯૦૬૦૩.૨૦૬૧૦.૭૦૬૨,૮૩૪
2026-04-02૫૯૦.૧૦૬૧૫.૦૦૫૮૩.૯૫૬૧૨.૨૦૯૬,૯૭૪
2026-04-01૫૬૯.૯૫૬૧૩.૦૫૫૬૯.૯૫૬૦૧.૦૦૨.૦૯L
2026-03-27૫૯૩.૦૦૬૦૯.૭૦૫૭૯.૬૫૫૮૭.૫૫૨.૬૮L
2026-03-25૫૭૪.૮૦૬૦૫.૯૫૫૭૪.૧૦૫૯૨.૬૦૨.૨૫L
2026-03-24૫૬૨.૩૦૫૭૯.૦૦૫૪૫.૫૦૫૬૪.૩૫૩.૨૯L
2026-03-20૫૮૨.૦૦૫૯૨.૫૦૫૮૨.૦૦૫૮૪.૨૦૯૫,૭૬૫
2026-03-19૫૭૬.૦૦૫૮૭.૫૦૫૭૬.૦૦૫૭૯.૯૦૧.૪૩L
2026-03-18૫૭૬.૦૦૫૯૮.૯૦૫૭૬.૦૦૫૮૯.૨૫૧.૬૪L
2026-03-17૫૮૦.૦૦૫૯૫.૯૫૫૭૦.૨૦૫૭૪.૫૦૧.૪૦L
2026-03-16૫૭૩.૦૦૫૮૮.૦૦૫૬૫.૦૦૫૭૩.૮૦૧.૭૫L
2026-03-13૫૮૯.૬૫૬૦૫.૦૦૫૭૪.૫૫૫૭૬.૯૦૨.૬૩L
2026-03-12૫૯૬.૫૫૬૦૩.૯૦૫૮૧.૯૦૫૮૫.૮૦૨.૩૦L
2026-03-11૬૧૦.૦૦૬૧૪.૦૦૫૯૫.૦૦૫૯૬.૫૫૭૪,૩૮૭

વારંવાર પૂછાતા પ્રશ્નો

વિશે

સુપ્રિયા લાઇફસાયન્સ લિમિટેડ, 1987 માં સ્થપાયેલ, મુંબઈ સ્થિત એક અગ્રણી ભારતીય જેનરિક ફાર્માસ્યુટિકલ કંપની છે, જે એન્ટિહિસ્ટામાઇન્સ, એન્ટિ-એલર્જીમેટિક સારવાર સહિત વિવિધ ઉપચારાત્મક ક્ષેત્રો માટે બલ્ક દવાઓ અને સક્રિય ફાર્માસ્યુટિકલ ઘટકો (APIs) ના સંશોધન, વિકાસ, ઉત્પાદન અને વેચાણમાં વિશેષતા ધરાવે છે. કંપની API અને ફાર્માસ્યુટિકલ રસાયણો પર ધ્યાન કેન્દ્રિત કરીને વૈશ્વિક ફાર્માસ્યુટિકલ બજારને પૂરી કરે છે, જે જેનરિક દવાઓની સપ્લાય ચેઇનમાં નોંધપાત્ર યોગદાન આપે છે.

BOARD OF DIRECTORS